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Intramembranous ossiﬁcation is a complex multi-step process which relies on extensive interactions
among bone cells and surrounding tissues. The embryonic vasculature is essential in regulating en-
dochondral ossiﬁcation; however, its role during intramembranous ossiﬁcation remains poorly under-
stood, and in vivo studies are lacking. Previous research from our lab on the development of the in-
tramembranous scleral ossicles has demonstrated an intriguing pattern of vascular development in
which the areas of future osteogenesis remain avascular until after bone induction has occurred. Such
avascular zones are located directly beneath each of the conjunctival papillae, epithelial structures which
provide osteogenic signals to the underlying mesenchyme. Here we provide a high-resolution map of the
developing vasculature from the time of ossicle induction to mineralization using a novel technique. We
show that vegfa is expressed by the papillae and nearby mesenchymal tissue throughout HH 34–37,
when vascular growth is taking place, and is down-regulated thereafter. Localized inhibition of Vegf
results in expansion of the avascular zone surrounding the implanted papilla and mispatterning of the
scleral ossicles. These results demonstrate that Vegf signaling could provide important insights into the
complex relationship between bone and vasculature during intramembranous bone development.
& 2015 Elsevier Inc. All rights reserved.1. Introduction
Intramembranous ossiﬁcation is the process by which bones
are formed via direct deposition of bone within a connective tissue
membrane. Unlike endochondral ossiﬁcation, a cartilage template
is not involved. Intramembranous ossiﬁcation requires that me-
senchymal precursor cells form a dense cluster, or condensation,
differentiate into osteoblasts and secrete collagen-rich osteoid
which then undergoes mineralization.
Extensive interactions with the surrounding vasculature are
required for the formation, maintenance and repair of en-
dochondral (Yin and Paciﬁci, 2001; Jacobsen et al., 2008; Eshkar-
Oren et al., 2009; Duan et al., 2015; Wiszniak et al., 2015) and
intramembranous (Thompson et al., 1989; Zelzer et al., 2002; Ja-
cobsen et al., 2008) bones. During endochondral ossiﬁcation of the
limb skeleton, for instance, remodeling of the vasculature occurs in
a number of predictable steps. First, although the early limb bud
contains a nearly homogeneous vascular meshwork, vessels re-
gress away from areas in which condensations will develop (Hurle,
1985; Eshkar-Oren et al., 2009). Once the cartilage element has(T.A. Franz-Odendaal).formed, the surrounding vasculature is remodeled to serve the
perichondrium but not the cartilage matrix or chondrocytes. Fi-
nally, vasculature invades the hypertrophic zone of the cartilage
and carries with it the chondroclasts and osteoblasts required to
replace the cartilage template with bone (Maes et al., 2010). Al-
though osteogenic condensations also form in avascular zones
(Thompson et al., 1989; Jourdeuil and Franz-Odendaal, 2012), the
role of vasculature during the development of intramembranous
bones is not well understood. Indeed, compared to endochondral
bones, intramembranous bones have received little attention in
the literature (Percival and Richtsmeier, 2013). In order to examine
the complex relationship between vasculature and bone we stu-
died an easily accessible, neural crest-derived ring of in-
tramembranous bones in the chick skull, the sclerotic ring. This
ring is made up of 13–16 individual scleral ossicles that provide
structural support to the eye. Each ossicle is attached to its
neighbors by dense connective tissue, and they together form the
sclerotic ring (Franz-Odendaal and Vickaryous, 2006).
Scleral ossicles develop in the eyes of birds and other reptiles in
a 1:1 relationship with overlying epithelial structures termed
conjunctival papillae (Murray, 1941; Coulombre, et al., 1962; Franz-
Odendaal and Vickaryous, 2006). The papillae develop in a con-
served pattern as follows. The ﬁrst papilla forms at Hamburger and
Hamilton stage 30 (HH 30) directly over the ciliary artery, and is
Fig. 1. (A) Schematic showing the numbering convention of the conjunctival papillae and scleral ossicles. Papilla #12 forms directly over the ciliary artery (not shown) and all
other papillae are numbered according to their position relative to #12. Anterior is to the right. (B) Cross section through two conjunctival papillae. The papillae are epithelial
structures which overlie the scleral mesenchyme. The space between neighboring papillae is termed the interpapillary region. The scleral ossicle condensations form in the
mesenchyme directly below each papilla.
J. Jabalee, T.A. Franz-Odendaal / Developmental Biology 406 (2015) 52–62 53designated papilla #12. This is followed by the remainder of the
temporal group (#10-14), the nasal group (#2-6), the dorsal group
(#7-9) and ﬁnally a ventral papilla (#1) forms directly over the
choroid ﬁssure (Coulombre et al., 1962; Franz-Odendaal, 2008;
Fig. 1A). The ring of papillae is completely formed by HH 34 (Franz-
Odendaal, 2008). The papillae are separated from one another by
an interpapillary zone (Fig. 1B). The conjunctival papillae induce
the formation of the ossicles in the underlying scleral mesench-
yme beginning at HH 35 (Fig. 1B); the papillae then slowly de-
generate over the next 1.5–2 days (Coulombre et al., 1962; Van de
Kamp, 1968; Franz-Odendaal, 2008). Since the papillae develop at
different times around the eye, the induction of the underlying
scleral ossicles is similarly staggered. The skeletogenic condensa-
tions are ﬁrst visible in the mesenchyme in histological section by
HH 36.5 (Jabalee et al., 2013). These condensed cells differentiate
into osteoblasts and deposit osteoid until approximately HH 38,
when mineralization begins (Franz-Odendaal, 2008; Zhang et al.,
2012).
Recently we used a combination of camera lucida drawings and
erythrocyte autoﬂuorescence to demonstrate that vasculogenesis
begins in the sclera of the chick eye at HH 34, the same time at
which the complete papilla ring has formed (Jourdeuil and Franz-
Odendaal, 2012). These small, open-ended vessels continue to
branch and connect with one another, forming a vessel meshwork
at HH 35. Interestingly, distinct avascular zones are seen below the
base of the papillae in the temporal region, much like the avas-
cular zones which precede limb cartilage formation (Eshkar-Oren
et al., 2009; Jourdeuil and Franz-Odendaal, 2012). In the limb,
vascular regression results in localized areas of hypoxia (low
oxygen tension) thought to be necessary for chondrocyte differ-
entiation (Amarilio et al., 2007; Provot et al., 2007). That avascular
zones precede the formation intramembranous bones during de-
velopment is especially odd given the apparent inverse correlation
between hypoxia and osteoblast differentiation demonstrated in
cell culture (Salim et al., 2004; D’Ippolito et al., 2006).
This study furthers our recent exploration into the role of
vasculature in scleral ossicle development. First, we re-visit vas-
cular growth in the sclera using a novel high-resolution technique
(Takase et al., 2013) and extend our analysis to older stages not
previously examined. This technique only detects blood vessels
that have connected with the main vascular system of the embryo
and exhibits much higher resolution than erythrocyte auto-
ﬂuorescence used previously (Jourdeuil and Franz-Odendaal,
2012), particularly at advanced stages of development. We then
analyzed the expression of vascular endothelial growth factor A
(vegfa) using in situ hybridization from HH 34–38.5. Vegf is a well-
known regulator of angiogenesis and plays a key role incoordinating blood vessel formation with bone development
during endochondral ossiﬁcation (Zelzer and Olsen 2005; Eshkar-
Oren et al., 2009) and bone repair (Street et al., 2002). Despite the
importance of Vegf in these processes, comparative expression
data for endochondral versus intramembranous bones is not
available. We then inhibited Vegf by implanting inhibitor-soaked
beads adjacent to individual papillae at HH 35, the onset of ossicle
induction. A combination of ink-injection and alkaline phospha-
tase staining was used to determine the effect of this Vegf in-
hibition on scleral vasculature and ossicles, respectively.
Our results demonstrate that Vegf plays a key role in regulating
ossicle growth, but vegfa is not expressed by osteoblasts themselves.
Instead, the papillae and surrounding superﬁcial mesenchyme act as
a source of Vegf beginning just prior to ossicle induction and ending
as the papillae degenerate. Not surprisingly, Vegf inhibition causes an
increase in the size of the avascular zone surrounding the bead.
Collectively, the data shows that papilla-derived Vegf is an important
regulator of vascular growth and patterning. Furthermore, Vegf in-
hibition results in abnormal sclerotic ring development, indicating
that Vegf may also be important for condensation formation and/or
osteoblast differentiation.2. Materials and methods
2.1. Chicken embryos
Fertilized White Leghorn (Gallus gallus) eggs were obtained
from the Nova Scotia Agricultural College (Truro, NS) or Cox
Brothers Farm (Truro, NS) depending on availability. Eggs were
incubated at 3771 °C, 40% humidity and were turned 1–2 times
daily. On the third day of incubation, eggs were windowed as
previously described (Silver, 1960; Korn and Cramer, 2007).
Chicken embryos were staged according to the Hamburger and
Hamilton (1951) staging series.
2.2. In situ hybridization
Plasmids containing vegfa were a kind gift from Todd Camenisch
(University of Arizona, USA). Whole-mount in situ hybridization was
performed as previously described (Nieto et al., 1996; Franz-Oden-
daal, 2008) with modiﬁcation. Half-heads were reacted with anti-
sense probe at each stage examined. Embryos receiving either no
probe or sense probe were used as negative controls. Whole-mount
stained tissues were cryosectioned at 10–12 mm thickness.
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Afﬁ-gel blue agarose beads (Bio-Rad, 153-7302), approximately
60–80 mm in diameter, were rinsed in sterile 1 phosphate buf-
fered saline (1 PBS; pH 7.4) before use. Beads were absorbed
with 100 mg/ml sFlt-1 (R&D Systems, 321-FL-050/CF), a soluble
form of Vegfr-1 which has been shown to bind and inactivate
extracellular Vegf in mammals (Kendall et al., 1996) and in avians
(Yamaguchi et al., 2002). Control beads were rinsed and absorbed
with PBS.
Membranes overlying chick embryos were dissected two days
prior to bead implantation (at HH 33) in order to improve access to
the eye. At this stage, the chorioallantoic membrane (CAM) re-
mains open near the posterior of the embryo. The opening was
torn using ﬁne forceps and the edge of the CAM was then gently
separated from the underlying yolk sac by tearing the thin, avas-
cular membrane which connects them. This prevents the CAM
from sealing over before the day of implantation, allowing the
surgery to be performed without tearing of CAM vasculature,
which results in a high rate of mortality.
To implant a bead, a ﬁne tungsten needle was used to create a
small epithelial slit adjacent to a papilla as previously described
(Franz-Odendaal, 2008; Duench and Franz-Odendaal, 2012). The
precise papilla targeted was determined by the orientation of the
embryo and was carefully noted. The temporal, nasal and dorsal
groups received approximately equal numbers of implantations.
Beads were transferred onto the eye and tucked into the epithelial
slit using sterile forceps or a blunt tungsten needle. Embryos were
treated with 40 ml penicillin-streptomycin (Sigma, P4458), sealed
with Scotch tape and incubated at 37 °C for one or two days post-
surgery (dps). Embryos were then injected with highlighter ink as
described below and ﬁxed in 4% PFA. Embryos implanted with
PBS-soaked beads were used as controls.2.4. Vasculature visualization and analysis
In order to visualize the scleral vasculature, 7.5 ml ink from a
yellow Pilot Spotliter brand highlighter pen was injected into the
vitelline artery using a pulled glass micropipette inserted into a
mouth pipette according to the protocol of Takase et al. (2013).
Embryos were incubated for 10 min at 37 °C to allow the ink to
circulate prior to ﬁxation in 4% PFA.
The anterior segment of each eye, including the cornea and
sclera, was dissected, and the lens, neural retina, and retinal pig-
mented epithelium were removed. The eye was ﬂat mounted and
ﬂuorescent images were obtained using a Nikon SMX 1500 mi-
croscope with a Nikon Intensilight C-HGFI illuminator. The area
tool in NIS Elements (Nikon Software, BR 3.00) was used to care-
fully outline avascular zones. To reduce measurement error, the
avascular zone surrounding a particular bead was measured three
times and the average of these measurements was used in sub-
sequent calculations. This procedure was repeated for the avas-
cular zone surrounding the equivalent papilla on the contralateral
eye of each embryo. A ratio was calculated for each embryo as the
quotient of the area measurement for the avascular zone sur-
rounding the implanted and unimplanted (contralateral) eye. Ad-
ditionally, the difference in area between the implanted and un-
implanted (contralateral) eyes was calculated for each embryo and
a constant added to each value. The square root of this value was
then taken to normalize the data. From this, an average area was
calculated for each group (sFlt-1 versus PBS) and statistical sig-
niﬁcance was calculated using an independent two-sample Stu-
dent's t-test or Analysis of Variance (ANOVA; Minitab version 14).2.5. Alkaline phosphatase staining
Alkaline phosphatase is an enzyme produced by a number of
cell types including preosteoblasts and osteoblasts, thereby mak-
ing it a useful indicator of early osteoblast differentiation and ac-
tivity (Stein et al., 1990; Weinreb et al., 1990). The enzymatic al-
kaline phosphatase staining protocol was performed on whole-
mount eyes as previously described (Edsall and Franz-Odendaal,
2010). Brieﬂy, ﬁxed tissues were washed in distilled water and
equilibrated in tris-maleate buffer [2.4% tris, 2.2% maleic acid
(Fisher Scientiﬁc, 03417); pH 8.3] for one hour. Embryos were
stained via reaction with AP substrate solution [1 mg/ml napthol
AS-TR phosphate (Sigma, N6125), 1% N,N-dimethylformamide
(Sigma, 319937), 0.08% Fast Blue B salt (Sigma, D9805) in tris-
maleate buffer] to produce a colored precipitate. Embryos were
rinsed in saturated sodium borate water to stop the reaction,
bleached overnight in 0.3% H2O2/1% KOH and processed through a
graded glycerol series ending in 80% glycerol in 1% KOH.3. Results
3.1. Growth of scleral vasculature
Vasculature plays a key role in regulating the development (Yin
and Paciﬁci, 2001; Yin et al., 2002; Wang et al., 2007), growth
(Maes et al., 2010; Liu et al., 2012), and repair (Rabie et al., 2002;
Street et al., 2002; Pacicca et al., 2003; Jacobsen et al., 2008) of the
endochondral limb skeleton. In order to examine the role of vas-
culature during development of intramembranous scleral ossicles,
we injected highlighter ink into the vasculature of the embryonic
chick enabling us to visualize, with high resolution, scleral blood
vessels during the key stages of scleral ossicle development from
induction (HH 35) through to mineralization (HH 38.5).
At HH 35, scleral vasculature is found exclusively in the pos-
terior of the eye near the ciliary artery (Fig. 2). Here, a distinct
avascular zone is present beneath each of the papillae of the
temporal group (Fig. 2A, A’). The nasal region is avascular at this
stage (Fig 2A”). The scleral vasculature grows anteriorly through-
out HH 35 and at HH 36 the anterior of the eye is heavily vascu-
larized. Avascular zones are now present beneath the papillae of
the dorsal, ventral, and nasal groups but are no longer present
beneath the papillae of the temporal group (Fig. 2B–B”). At HH 37,
the sclera contains a nearly homogeneous meshwork of blood
vessels and avascular zones are no longer present beneath any of
the degenerating papillae. This phenotype persists into HH 38
with little noticeable change (Fig. 2C–C”). Thus, the scleral vascular
network is established and grows throughout the same develop-
mental time period during which the full papilla ring forms and
ossicles are induced (HH 34–36.5). Similarly, this meshwork is
complete just as the papillae degenerate at HH37. Furthermore,
the scleral vasculature is excluded from growing into the area that
surrounds each papilla, thereby forming an avascular zone. Each
avascular zone gradually decreases in size until it is abolished at
approximately the same time as the papilla which it surrounds.
Collectively, these results indicate that the development of the
conjunctival papillae and the scleral vasculature is likely co-
ordinated both spatially and temporally.
3.2. Vegfa expression during osteogenesis
Finding that angiogenesis and conjunctival papilla formation
are likely spatially and temporally coordinated led us to investigate
which tissues are responsible for producing the angiogenic signal
required to drive scleral vascularization. Since Vegf is known to
play a key role in coordinating blood vessel formation with bone
Fig. 2. Vascular growth in the sclera of the chick eye. (A) The vascular network of the sclera at HH 35. A dense vascular meshwork has been established posteriorly, and a
distinct avascular zone is present beneath each papilla of the temporal group (A’). Curved arrows in A show the direction of new vascular growth. Vasculature is absent
anteriorly in the region of the papillae (A’’). (B) The vascular network of the sclera at HH 36. The posterior of the eye is well vascularized and avascular zones are no longer
present (B’). The anterior of the eye is sparsely vascularized and large avascular zones are present beneath the nasal group papillae (black outline in B’’). (C) The vascular
network of the sclera at HH 38. The sclera is well vascularized posteriorly (C’) and anteriorly (C’’). Avascular zones are not present at this stage. Scale bars are 1000 µm.
Anterior is to the right. Avascular zones are outlined in black; papillae are outlined in white.
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2005; Eshkar-Oren et al., 2009), we performed whole-mount
in situ hybridization for vegfa from HH 34–38.5.
Vegfa is strongly expressed by the papillae of the nasal and
dorsal groups at HH 34 (Fig. 3A). Additionally, diffuse expression is
seen in the epithelium and superﬁcial mesenchyme adjacent to
each papilla, though distinct interpapillary regions can be identi-
ﬁed with little to no staining (Fig. 3A’, asterisk). Diffuse me-
senchymal expression is also observed in the temporal region
surrounding the ciliary artery (Fig. 3A”). At HH 35, vegfa expression
is seen in the entire ring of papillae, but is strongest in the nasal
and dorsal groups compared to the other groups (Fig. 3B–B”).
Additionally, expression is seen diffusely in the adjacent epithe-
lium and superﬁcial mesenchyme underlying each papilla; again,
distinct interpapillary regions can be identiﬁed with little to no
staining (Fig. 3B’, asterisk). By HH 36.5 the temporal group papillae
have degenerated and little to no vegfa expression is seen in the
posterior region of the eye (Fig. 3C). Anteriorly, expression persists
in the degenerating papillae and diffuse expression is seen
throughout the adjacent epithelium and superﬁcial mesenchyme
(Fig. 3C). At HH 37, all the papillae have degenerated but diffuse
expression is still visible in the anterior scleral mesenchyme
(Fig. 3D). Vegfa is gradually down-regulated until expression is no
longer visible by HH 38.5 (Fig. 3E). To determine if vegfa is ex-
pressed by osteoblasts during osteoid deposition, we examinedthe developing scleral ossicles in section at HH 37. Interestingly,
vegfa expression is seen in the conjunctival epithelium and su-
perﬁcial mesenchyme but is not expressed by the osteoblasts of
the scleral ossicles (Fig. 3F). This is in contrast to the beak, in which
expression can be seen in the developing premaxilla (Fig. S1). In
summary, this data clearly shows that vegfa is expressed most
strongly in the papillae themselves as they develop and induce the
underlying scleral ossicles (HH 34–36.5). These stages correlate
with when growth of the scleral vasculature occurs. Collectively,
these results suggest that Vegf may play a role in regulating scleral
angiogenesis and/or osteogenesis.
3.3. Loss of Vegf signaling results in abnormal vascular development
in the sclera
To further investigate whether Vegf produced by the papillae
and surrounding mesenchyme plays a role in regulating the
growth of the scleral vasculature we implanted beads soaked in
100 mg/ml sFlt-1 adjacent to an individual papilla at HH 35 and
allowed embryos to develop for one or two days. sFlt-1 is a soluble
form of Vegfr-1 that binds and inactivates extracellular Vegf
(Kendall et al., 1996; Yamaguchi et al., 2002). We then measured
the size of the avascular zone surrounding the area of implantation
compared to that of the equivalent region of the unimplanted
(contralateral) eye of the same embryo.
Fig. 3. Vegfa in situ hybridization. (A) At HH 34, vegfa is expressed by the papillae of the nasal and dorsal groups and is expressed diffusely in the adjacent epithelium and
superﬁcial mesenchyme (A’); however, between each papilla is a distinct interpapillary region lacking expression (A’, asterisk). Vegfa is also expressed diffusely in the
epithelium and superﬁcial mesenchyme of the temporal region of the eye (A’’). (B) At HH 35, vegfa is expressed in the conjunctival papillae and is expressed diffusely in the
adjacent epithelium and superﬁcial mesenchyme with the exception of a distinct interpapillary region which lacks expression (B’, asterisk). Expression is stronger in the
nasal and dorsal regions than in the temporal region (B’, B’’). (C) At HH 36.5, vegfa is expressed in the anterior conjunctival papillae (arrows) and is expressed diffusely in
the adjacent mesenchyme. Little to no expression is seen in the temporal region where papillae have degenerated (asterisk). (D) At HH 37, little to no vegfa expression is seen
in the temporal region of the eye (asterisk), but diffuse mesenchymal expression is detected anteriorly. (E) At HH 38.5, vegfa is not expressed in any region of the eye. (F)
Cryosection through an anterior condensation, HH 37. Vegfa expression is seen in the epithelium and superﬁcial mesenchyme. Deposited osteoid is outlined. Scale bars: 1000
µm in A-E; 20 µm in F. Anterior is to the right.
Fig. 4. Effect of sFlt-1-soaked bead implantation on scleral vasculature. (A-B) Eye implanted with a bead containing 100 µg/ml sFlt-1 visualized at 1 day post-surgery. The
avascular zone surrounding the bead (A) is enlarged compared to the contralateral unimplanted eye (B). (C-D) Eye implanted with a bead containing 100 µg/ml sFlt-1
visualized at 2 days post-surgery. The avascular zone is not present. Avascular zones are outlined in black; papillae are outlined in white. Scale bars are 500 µm.
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avascular zone between the implanted and unimplanted eye of
each embryo was signiﬁcantly greater for those embryos which
received sFlt-1 than those which received control beads (in-
dependent 2-sample t-test, t¼2.63; d.f.¼10; p¼0.025; Fig. 4A, B).
Additionally, in 45% of sFlt-1 implanted embryos (5/11), the
avascular zone surrounding the bead was more than 1.5 times
larger than the avascular zone surrounding the equivalent papilla
in the contralateral eye (Table 1). Such an increase was not ob-
served in any of the PBS controls. These results demonstrate that
Vegf secreted by the conjunctival epithelial papillae plays a key
role in regulating the growth of the scleral vasculature.
At 2 dps, embryos have reached HH 37. Earlier in the study we
showed that avascular zones are not typically present at this stage;
rather, the sclera is ﬁlled with a dense meshwork of small vessels.
Indeed, no avascular zone could be discerned surrounding sFlt-1-
soaked beads at this stage, and the same dense meshwork was
observed in controls (Fig. 4C, D). This result demonstrates that the
scleral vasculature is capable of recovering from sFlt-1 treatment
within two days of surgery.
3.4. Loss of Vegf signaling results in abnormal scleral ossicle
development
Finding that sFlt-1 treatment alters the formation of the scleral
vasculature prompted us to determine whether or not the scleral
ossicles are also affected by Vegf inhibition. To investigate the ef-
fect of sFlt-1 on bone development, we stained the developing
ossicles of sFlt-1-treated embryos for alkaline phosphatase to ob-
serve preosteoblasts and osteoblasts.
Treated embryos exhibited a variety of abnormal phenotypes
not typically seen in PBS controls. These mispatternings included
abnormal overlap between neighboring ossicles [ossicles do not
normally overlap one another until HH 38, (Franz-Odendaal,
2008)], large gaps between ossicles, understained ossicles show-
ing weak osteoblast activity, groups of ossicles in which the bor-
ders between neighbors have been lost (we call this phenotype
smearing), ossicles of abnormal size and/or shape, and missing or
ectopic ossicles (Fig. 5). Often, a single eye contained more than
one of the above mispatternings; thus, the effect of the bead was
not localized to the underlying and nearby ossicles but instead
tended to alter the sclerotic ring as a whole. Curiously, the ossicles
of the contralateral eye, which did not receive a bead, were also
altered despite showing no change in vasculature (Fig. S2).
In order to better understand the effect of sFlt-1 on scleral
ossicles, we classiﬁed the extent of ossicle mispatterning in eachTable 1
Effect of Vegf inhibition on avascular zones. The ratios were calculated from the
area measurements of the avascular zones in each eye as described in the methods.
Treatment Ratio (Exp/Ctrl)
Experimental eye sFlt-1 (100 mg/ml) 9.39
sFlt-1 (100 mg/ml) 5.01
sFlt-1 (100 mg/ml) 2.98
sFlt-1 (100 mg/ml) 1.76
sFlt-1 (100 mg/ml) 1.64
sFlt-1 (100 mg/ml) 1.34
sFlt-1 (100 mg/ml) 1.32
sFlt-1 (100 mg/ml) 1.25
sFlt-1 (100 mg/ml) 1.18
sFlt-1 (100 mg/ml) 1.04
sFlt-1 (100 mg/ml) 0.77
Control eye 1 PBS 1.41
1 PBS 0.91
1 PBS 0.76eye based on the number and type of mispatternings as follows
(examples are given in Fig. 5):
1. Normal – A complete absence of ossicle mispatterning.
2. Mild – Only one of the above-mentioned mispatternings
present.
3. Moderate – Two to three of the above-mentioned mispattern-
ings present.
4. Severe – More than three mispatternings or a completely
missing/ectopic ossicle present.
After classifying the stained eyes in this way, we found that
100% of the sFlt-1 implanted eyes contained at least mild mis-
patterning, compared to only half of PBS controls at 1 dps (Fig. 6A).
Furthermore, although severe mispatterning was not observed in
controls, over 25% of sFlt-1 implants exhibited this type of mis-
patterning. Interestingly, the contralateral (unimplanted) eyes of
sFlt-1-implanted embryos were also affected (Fig. S3). Indeed, over
70% of these eyes exhibit at least mild mispatterning, whereas
none of the contralateral eyes of PBS-implanted controls are
mispatterned (Fig. 6A). Interestingly, in the contralateral eyes of all
sFlt-1-implanted embryos analyzed (n¼33), only 33% of embryos
exhibited obvious mispatterning of the nasal group of ossicles
compared to 84% of temporal group ossicles. These results provide
direct evidence that Vegf is required for proper development of
the sclerotic ring.
Our earlier results showed that vasculature recovers from sFlt-1
treatment by 2 dps. We therefore wanted to determine whether
scleral ossicles are also able to recover after sFlt-1 treatment. Using
the same mispatterning classiﬁcation scheme described above, we
analyzed alkaline phosphatase-stained eyes two days after sFlt-1-
soaked bead implantation. Over 80% of sFlt-1-implanted eyes ex-
hibit at least mild mispatterning. Interestingly, the contralateral
eyes of these embryos showed a higher proportion of severe
mispatterning than at 1 dps (Fig. 6B). These results demonstrate
that scleral ossicles are not able to recover fully by 2 dps despite
fairly rapid vasculature recovery.
In order to better understand the relationship among Vegf in-
hibition, angiogenesis and osteogenesis, we compared the severity
of ossicle mispatterning with the change in vasculature of each
embryo. Interestingly, we did not ﬁnd a signiﬁcant difference in
the mean change in avascular zone size among embryos with
normal, mild, moderate, or severely mispatterned sclerotic rings
(ANOVA, F¼1.11; d.f.¼13; p¼0.389). Thus, rather than affecting
vasculature and bone with equal magnitude, Vegf inhibition re-
sults in an array of scleral ossicle abnormalities which are embryo-
speciﬁc. The mechanism(s) by which Vegf inhibition results in
ossicle mispatternings requires further research.4. Discussion
4.1. Conjunctival papillae regulate scleral vascular growth via Vegf
Previous work from our lab has shown that the vascular net-
work of the sclera begins to form de novo at HH 34 (Jourdeuil and
Franz-Odendaal, 2012), which is the time at which a full ring of
conjunctival papillae has already formed. Additionally, each papilla
is surrounded by a distinct avascular zone at the time of ossicle
induction, HH 35 (Jourdeuil and Franz-Odendaal, 2012). Here we
conﬁrm the presence of avascular zones using a novel technique
and add the following data:
i. Growth of the scleral vasculature begins in the posterior of the
eye, in the vicinity of the ciliary artery, and proceeds anteriorly.
ii. Avascular zones do not form in unison; instead, avascular zones
Fig. 5. Classiﬁcation of the severity of deviation from the normal pattern of scleral ossicle development following sFlt-1-soaked bead implantation at 1 and 2 dps (HH 36-37)
as visualized by alkaline phosphatase staining. (A-B) Normal. An absence of mispatterned ossicles. (C-D) Mild; one mispatterned ossicle. (E-F) Moderate; two to three
mispatterned ossicles. (G-H) Severe; either an excess of three mispatterned ossicles or an ectopic or missing ossicle. Mispatterned ossicles are deﬁned in the text. Scale bars
are 1000 µm.
J. Jabalee, T.A. Franz-Odendaal / Developmental Biology 406 (2015) 52–6258
J. Jabalee, T.A. Franz-Odendaal / Developmental Biology 406 (2015) 52–62 59form around the temporal group of papillae by HH 35 and
around the dorsal, ventral, and nasal papillae by HH 36.
iii. Avascular zones gradually decrease in size and are fully vas-
cularized by the time the overlying papilla has degenerated at
HH 37.
During limb development, blood vessels undergo regression away
from areas of future chondrogenesis (Hurle, 1985; Feinberg et al.,
1986; Yin and Paciﬁci, 2001; Eshkar-Oren et al., 2009) whereas here
we conﬁrm that in the chick scleral ossicle system the blood vessels
are excluded from invading the areas of future bone formation until
after osteogenesis has commenced (Thompson et al., 1989; Jourdeuil
and Franz-Odendaal, 2012). These observations may indicate a dif-
ference in the mechanism by which vasculature is patterned in re-
lation to cartilage and bone formation.
Vegf has been identiﬁed as a key regulator of both vascular and
bone development, particularly during endochondral ossiﬁcation
(Zelzer et al., 2001, 2002; Eshkar-Oren et al., 2009). Vegfa is ex-
pressed throughout the early limb bud but becomes increasingly
restricted to the cells of the developing cartilage elements and
eventually to the cells of the hypertrophic zone, where vascular
invasion will occur (Eshkar-Oren et al., 2009). Although vegfa ex-
pression has been documented in calvariae-derived osteoblasts in
culture (Deckers et al., 2000; Spector et al., 2001) and in miner-
alized intramembranous bones (Zelzer and Olsen 2005; De Spie-
gelaere et al., 2010), its expression pattern has not been examined
during the early stages of intramembranous bone development
such as during bone induction and condensation formation. Our
results show that vegfa is expressed strongly by the papillae at the
same time at which vascular growth is occurring in the sclera.
Expression decreases as the papillae degenerate and bone induc-Fig. 6. Severity of ossicle mispatterning in sFlt-1 versus PBS (control) embryos at 1 day p
each of the four categories of ossicle mispatterning (normal, mild, moderate, severe) aretion ends. The scleral vascular network is well established by the
time the papillae have degenerated completely. Furthermore, we
have shown that implantation of a bead soaked in the Vegf in-
hibitor sFlt-1 results in an increase in the size of the surrounding
avascular zone, suggesting that papillae-derived Vegf promotes
growth of scleral vasculature. Therefore, Vegf likely plays a role in
decreasing the size of the avascular zones as development pro-
ceeds. Presumably, an anti-angiogenic signal must also be present
or else avascular zones would never form. Indeed, recent studies
have shown that it is the balance between angiogenic and anti-
angiogenic signals that regulates vascularization of the cornea
(Kwiatkowski et al., 2013). Identifying these signals will help shed
additional light on how avascular zone size, preceding bone for-
mation, is regulated.
It is apparent that avascular zones play an important role in
skeletogenesis since all skeletal elements, bones and cartilages,
form in such zones (Hurle, 1985; Feinberg et al., 1986; Thompson
et al., 1989; Yin and Paciﬁci, 2001; Eshkar-Oren et al., 2009;
Jourdeuil and Franz-Odendaal, 2012; this study). The precise
function of avascular zones, however, remains poorly understood,
particularly during intramembranous ossiﬁcation. During forma-
tion of limb cartilages, avascular zones serve as localized areas of
low oxygen tension (hypoxia), and hypoxia drives the expression
of the chondrocyte-speciﬁc transcription factor sox9 via the action
of hypoxia inducible transcription factor 1 (HIF-1; Amarilio et al.,
2007). Thus, the avascular zones of the limb are required for
chondrogenic differentiation, and blocking avascular zone forma-
tion abolishes chondrogenesis (Yin and Paciﬁci, 2001).
Contrary to the positive effect of hypoxia on chondrocyte differ-
entiation, studies of osteoblast precursors in vitro suggest that hy-
poxia inhibits osteoblast differentiation (Park et al., 2002; Salim et al.,ost-surgery (A) and 2 days post-surgery (B). The proportion of embryos falling into
shown for sFlt-1 and PBS control eyes, as well as unimplanted (contralateral) eyes.
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have been shown to express HIF-2 but not HIF-1, suggesting that
osteoblasts respond to hypoxia differently than chondrocytes (De
Spiegelaere et al., 2010). If hypoxia inhibits osteoblast differentiation,
how and why do osteogenic condensations form in potentially hy-
poxic avascular zones? One possible explanation is that hypoxia acts
in addition to another signal, such as bone morphogenetic protein 2
(BMP2), to drive osteoblast differentiation during intramembranous
ossiﬁcation in vivo. Indeed, previous results from our lab have shown
that BMP2 is expressed by the papillae from HH 34.5 to 36, the time
at which avascular zones are present and ossicle induction is oc-
curring (Duench and Franz-Odendaal, 2012). Interestingly, addition
of exogenous BMP2 to calvariae-derived osteoblasts cultured under
anoxic conditions rescues the expression of runx2, a positive reg-
ulator of osteoblast differentiation (Salim et al., 2004), thereby pro-
viding support for this hypothesis.
In summary, we have shown that vegfa is expressed by the
papillae (and superﬁcial mesenchyme) at the same stages during
which scleral vascular growth is underway. Inhibition of this Vegf
signal results in a distinct but temporary increase in avascular
zone size, and has a long-term effect on bone formation. Together
these results suggest that the epithelial papillae play a key role in
the regulation of blood vessel growth and patterning within the
chick scleral mesenchyme by signaling through the Vegf pathway.
4.2. Vegf affects intramembranous bone patterning
Previous research has shown a strong association between
vegfa expression and osteoblast differentiation in vitro. Calvariae-
derived preosteoblasts express vegfa at low levels during early
differentiation and expression increases as mineralized bone no-
dules begin to form (Deckers et al., 2000). Furthermore, the ad-
dition of exogenous Vegf to preosteoblast cultures has been shown
to stimulate the expression of bone-speciﬁc genes and enhance
bone nodule formation (Midy and Plouët, 1994; Deckers et al.,
2000). These studies suggest an important role for Vegf in osteo-
blast differentiation.
Based on the results of the in vitro studies described above, we
expected to detect vegfa expression in osteoblasts lining the ossicle
condensations as they began to mineralize. Instead, we found that
osteoblasts do not express vegfa at any of the stages examined. We
offer a few potential explanations. Firstly, it may be that early
osteoblasts express a tissue-speciﬁc Vegf not detected by our ri-
boprobe, similar to endocrine-gland-derived Vegf (LeCouter et al.,
2001). Other such tissue-speciﬁc forms of Vegf have been hy-
pothesized to exist in vertebrates but have yet to be identiﬁed
(LeCouter et al., 2001; LeCouter and Ferrara, 2002). Secondly, the
detection of vegfa expression in vitro may be an artifact of cul-
turing. Vegfa expression is often driven by hypoxia, which results
from an absence of vasculature (Steinbrech et al., 2000; Spector
et al., 2001; Amarilio et al., 2007). In culture, the developing bone
nodules do not become vascularized and therefore may express
vegfa at high levels in an effort to stimulate angiogenesis. In the
chick sclera, however, vascularization is regulated by Vegf derived
primarily from the papillae, and avascular zones are vascularized
concomitant with condensation formation.
Despite a lack of vegfa expression by osteoblasts themselves,
our results show that inhibiting Vegf has a profound effect on the
development of the scleral ossicles and on the sclerotic ring as a
whole. However, the mechanism underlying this effect remains
unclear. We propose the following scenarios: (1) Vegf inhibition
results in vascular abnormalities, which in turn drive ossicle mis-
patterning. In this scenario, endothelial cells provide osteoblasts
and/or their precursors with a signal necessary for proper devel-
opment, such as promoting cell survival, differentiation, or pro-
liferation. Such endothelial cell-osteoblast cross-talk has beendescribed to play a role during endochondral ossiﬁcation (Ku-
sumbe et al., 2014; Ramasamy et al., 2014). If this scenario is cor-
rect, treatment with an antiangiogenic substance that is not Vegf is
expected to yield ossicle phenotypes similar to those observed in
the current study. (2) Vegf itself is required by osteoblasts and/or
their precursors for proper development. If this scenario is correct,
then osteoblasts should express Vegf receptors, and treatment
with an antiangiogenic substance is not expected to yield abnor-
mal ossicle phenotypes. While Vegf receptor expression by cal-
variae-derived osteoblasts has been described in culture (Deckers
et al., 2000), similar experiments have not been carried out in the
scleral ossicle system in vivo. (3) Vegf does not speciﬁcally target
osteoblasts but is instead required for cell survival more generally.
In this scenario, Vegf inhibition results in widespread cell death
affecting multiple cell types in the vicinity of the implanted bead,
thereby disrupting development in this region. If this alternative is
correct, such widespread cell death should be detectable in the
hours following bead implantation. (4) Vegf plays some as yet
unknown or unexpected function, and/or cells respond in some
unexpected way. Recent studies are beginning to bring to light the
full complexity of Vegf signaling, and there is likely much left to
learn (LeCouter and Ferrara, 2002; Liu et al., 2012; Wiszniak et al.,
2015). Indeed, it is perhaps most likely that it is not one of the
above but some combination which actually occurs. The functions
of Vegf are likely dependent on dose and timing, thereby adding
additional complexity to its study. Teasing apart the intricate in-
teractions among Vegf, angiogenesis and osteogenesis is a monu-
mental task, but one that is required to bring about a deeper un-
derstanding of skeletal development.
Furthermore, our results also demonstrate that the effects of
Vegf inhibition are not localized to a single ossicle. Rather, sFlt-1-
soaked beads caused mispatterning of ossicles throughout the
sclerotic ring, and even affected the ossicles of the contralateral,
unimplanted eye. How this occurs, however, remains unclear.
Previous research from our lab has shown that loss of an ossicle is
compensated for by an increase in size of the other ossicles in the
ring, speciﬁcally those next in the sequence to develop (Franz-
Odendaal, 2008; Duench and Franz-Odendaal, 2012). Similar
compensatory mechanisms may partially explain why Vegf in-
hibition results in multiple mispatternings within the same eye.
Although sFlt-1 may affect only one or a small group of ossicles
directly, additional mispatternings may occur as the unaffected
ossicles adjust to the mispatternings of their neighbors. Equally
unclear is how an inhibitor applied to one eye can affect the os-
sicles of the contralateral eye. This phenomenon was not observed
when ossicles were treated with either cyclopamine or noggin in
our previous studies (Franz-Odendaal, 2008; Duench and Franz-
Odendaal, 2012) and currently there is no satisfactory explanation.
One possibility is that sFlt-1 travels through the vasculature itself
from the site of implantation to the mesenchyme of the con-
tralateral eye. Interestingly, we observed that the nasal group of
ossicles in the unimplanted contralateral eyes, which have not yet
been approached by vasculature at the time of bead implantation,
are rarely affected. Instead, the temporal group of ossicles in the
posterior region of the unimplanted eye is predominately affected,
as described in the Results. This posterior region is well vascular-
ized at both the time of implantation and at the time of ﬁxation,
and also includes the large ciliary artery. Implantation of a bead
soaked in sFlt-1 which has been ﬂuorescently tagged would allow
diffusion and localization of the protein to be analyzed in real
time, thereby providing a means to determine whether movement
of sFlt-1 into the contralateral eye actually occurs.
5. Conclusions
The scleral ossicles of the chick embryo provide a useful but
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process of intramembranous ossiﬁcation. Building on previous work
from our lab, we use this model system to further our understanding
of the role of the embryonic vasculature and of Vegf during osteo-
genesis. We show that avascular zones are present at the time of
ossicle induction and are vascularized as papillae degenerate and
induction ends. Similarly, expression of vegfa is strongest at the time
of induction and gradually decreases as the papillae degenerate until
it is eventually lost. Contrary to what we expected, vegfa is expressed
strongly by the papillae but not by osteoblasts at any of the stages
examined. This is in contrast to the events of endochondral ossiﬁ-
cation, during which vegfa expression is restricted to the developing
cartilage element (Eshkar-Oren et al., 2009).
Furthermore, we show that localized inhibition of Vegf sig-
naling via implantation of beads soaked in sFlt-1 alters the de-
velopment of both the scleral vasculature and ossicles, suggesting
that Vegf plays a role in one or both of these processes. Although
more investigation is required, it is clear that Vegf is required for
the patterning of intramembranous bones. In a ﬁeld which relies
heavily on cell culture studies, scleral ossicles provide a fresh
in vivo system in which to tackle such pursuits.Acknowledgments
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